Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience
Mauricio G. Cohen(Santa Ana College), William W. O’Neill(Henry Ford Hospital), Simon Dixon(Beaumont Hospital, Royal Oak), Theodore Schreiber(Detroit Medical Center), Ray Matthews, E. Magnus Ohman(Tarzana Treatment Centers), George W. Vetrovec(Virginia Commonwealth University), Brij Maini(Delray Medical Center), Jeffrey J. Popma(Cardiovascular Research Foundation), Igor F. Palacios(Massachusetts General Hospital), David Wohns(Spectrum Health)
Cited by 65
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k